- AU$8.58bn
- AU$8.60bn
- AU$2.35bn
Australia's Cochlear hit with shareholder lawsuit over 2026 earnings forecast (updated)
Australia's Cochlear falls after shareholder class action over FY2026 profit forecast
Cochlear to defend shareholder class action over 2026 profit forecast
Brief: Cochlear says class action claim filed against it in Supreme Court of Victoria
Cochlear, Sonic Healthcare fall on MSCI Australia Index exit
Australia's Cochlear set for biggest gain in more than a year after FY earnings beat
Brief: Cochlear Sees Net Profit Margin To Return To 18% Over Medium Term
Brief: Cochlear Posts FY Sales Of AUD 2,343.4 Million
Brief: MSCI Says There Will Be 184 Additions To The MSCI ACWI IMI Index
Australia's Cochlear gains on US import win after investigation
Brief: Cochlear Confirms It Will Continue To Be Able To Import Its Hearing Implant Systems Into US Duty- Free
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX
Morningstar backs Australia's Cochlear on new hearing implant product
Australia's Cochlear set for worst week ever on earnings forecast cut
Australian healthcare stocks hit 8-year low as CSL extends vaccine rout
Australia's Cochlear extends losses on rating downgrade after earnings forecast cut
Citi reduces PT for Australia's Cochlear post weak trading update
Sonova leads European hearing-care stocks lower after Cochlear warning
Australia's Cochlear slips; Jarden flags weak demand on Middle East conflict disruptions